The Drug Regulatory of Pakistan has recently approved two COVID-19 vaccines for emergency use. These are the ones developed by China’s Sinopharm and US firm AstraZeneca together with Oxford University. SAMAA Health discusses the efficacy, safety profiles and storage requirements of the two as well as that of the Cansino Bio coronavirus vaccine that is being tried in Pakistan.


Similar articles:

  1. Pfizer vaccine effective against UK strain, preliminary studies show []

Leave a Reply

Your email address will not be published. Required fields are marked *